Correlation Between AnaptysBio and Olema Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both AnaptysBio and Olema Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AnaptysBio and Olema Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AnaptysBio and Olema Pharmaceuticals, you can compare the effects of market volatilities on AnaptysBio and Olema Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AnaptysBio with a short position of Olema Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of AnaptysBio and Olema Pharmaceuticals.
Diversification Opportunities for AnaptysBio and Olema Pharmaceuticals
0.57 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between AnaptysBio and Olema is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding AnaptysBio and Olema Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Olema Pharmaceuticals and AnaptysBio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AnaptysBio are associated (or correlated) with Olema Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Olema Pharmaceuticals has no effect on the direction of AnaptysBio i.e., AnaptysBio and Olema Pharmaceuticals go up and down completely randomly.
Pair Corralation between AnaptysBio and Olema Pharmaceuticals
Given the investment horizon of 90 days AnaptysBio is expected to generate 1.37 times more return on investment than Olema Pharmaceuticals. However, AnaptysBio is 1.37 times more volatile than Olema Pharmaceuticals. It trades about -0.06 of its potential returns per unit of risk. Olema Pharmaceuticals is currently generating about -0.1 per unit of risk. If you would invest 3,187 in AnaptysBio on August 28, 2024 and sell it today you would lose (662.00) from holding AnaptysBio or give up 20.77% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
AnaptysBio vs. Olema Pharmaceuticals
Performance |
| Timeline |
| AnaptysBio |
| Olema Pharmaceuticals |
AnaptysBio and Olema Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AnaptysBio and Olema Pharmaceuticals
The main advantage of trading using opposite AnaptysBio and Olema Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AnaptysBio position performs unexpectedly, Olema Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Olema Pharmaceuticals will offset losses from the drop in Olema Pharmaceuticals' long position.| AnaptysBio vs. Crinetics Pharmaceuticals | AnaptysBio vs. Rhythm Pharmaceuticals | AnaptysBio vs. Kura Oncology | AnaptysBio vs. CytomX Therapeutics |
| Olema Pharmaceuticals vs. Sana Biotechnology | Olema Pharmaceuticals vs. Cullinan Oncology LLC | Olema Pharmaceuticals vs. Zentalis Pharmaceuticals Llc | Olema Pharmaceuticals vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |